Geetha K

Abstract

Background: COVID-19 pandemic has caused marked economic, social, and health impacts. People affected by leprosy have additionally been hit via way of means by the pandemic. Many patients have missed their monthly medications. Here is a report of one such case who presented with vasculonecrotic erythema nodosum due to discontinuation of MB MDT therapy. Case presentation: A 26-year-old man affected with leprosy presented to our OPD with a 2- month history of fever, hemorrhagic blisters and ulcers over extremities. On examination, purpuric plaques, hemorrhagic bullae and necrotic ulcers were found on the face and extremities along with erythematous edematous lesions on the trunk. The diagnosis of vasculonecrotic erythema nodosum was made with the characteristic clinical and diagnostic features. Conclusion: Leprosy is a chronic disease with various atypical, rare and unrecognizable manifestations. Early diagnosis and prompt treatment are needed to reduce morbidity and mortality. In this Covid situation, special attention should be paid to chronic diseases such as leprosy by giving appropriate guidelines on how to treat them. Keywords: Covid 19, Leprosy, Vasculonecrotic erythema nodosum

View Article

Abstract

Various cutaneous manifestations have been reported after receiving the COVID-19 vaccine of different types. The commonest reactions were delayed large local reactions, local injection site reactions, urticaria, and morbilliform eruptions following mRNA vaccines. There are very few reports of erythema multiforme (EM) and pityriasis rosea(PR) following Covid vaccines. Erythema multiforme (EM) is one of the commonest reaction following viral infections, drugs and vaccines. Here we are reporting a case of atypical erythema multiforme like pityriasis rosea manifestation following Covishield Covid vaccine second dose.   Keywords: Erythema multiforme, Pityriasis rosea, Covid vaccine

View Article